Europe Archives - Page 49 of 93 - Journal for Clinical Studies

Current Edition

Europe

New cancer drug safely boosts radiation therapy

A new clinical trial tests a radiotherapy-boosting drug in the fight against various forms of cancer. New research finds a safe way to boost the effects of radiatio...

22 November 2018 Europe | news | Regional News

Continue Reading →

Europe

ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research

LYON, France and CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company develo...

22 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Quanticate Sponsors Research into Response-Adaptive Trial Design

LONDON (UK) - Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD p...

22 November 2018 Europe | news

Continue Reading →

Australasia

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space. Philadelphia, USA – November 14, 2018 PCI Pharma Services (PCI), a full-service provider of...

Continue Reading →

Europe

Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE-Therapeutics

NBE Therapeutics AG, a biopharmaceutical company developing next-generation immune-stimulatory antibody-drug conjugates (iADCs™) for improved cancer therapy, today an...

15 November 2018 Europe | news

Continue Reading →

Europe

Ionis, Akcea succeed in heart drug trial, setting up Novartis decision

Akcea Therapeutics and Ionis Pharmaceuticals rolled out successful Phase 2 study results Wednesday showing their drug candidate lowered Lp(a), short for lipoprotein(a...

15 November 2018 Europe | news | North America

Continue Reading →

Europe

‘Super’-responder analysis gives more power to Viking’s fatty liver drug

Researchers Monday presented more complete results from Viking Therapeutics' 12-week Phase 2 study of VK2809 at The Liver Meeting 2018, after previously announcing in...

15 November 2018 Europe | news | North America

Continue Reading →

Europe

Chronic inflammation linked with increased risk of multiple diseases and shorter lifespan

Researchers have elucidated the disease risk underlying a biomarker predictive of shorter lifespan. Researchers have been able to unravel the disease burden that unde...

8 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes

Excellent safety profile reported so far, results expected summer 2019 Liège, Belgium, November 5, 2018 – Imcyse, who develop active specific immunotherapies for the ...

8 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases

Candidate molecules have the potential to treat multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and systemic inflammatory disea...

8 November 2018 Europe | news | Regional News

Continue Reading →